Home

orice mercenar cowboy atc anti markeri anticoag hepatic Cincizeci A incuraja Karu

PDF) Oral Anticoagulation in Patients With Liver Disease
PDF) Oral Anticoagulation in Patients With Liver Disease

A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome -  ScienceDirect
A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome - ScienceDirect

PDF) Anticoagulant therapy in patients with liver cirrhosis and portal vein  thrombosis: insights for the clinician
PDF) Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician

Anticoagulants and Transaminase Elevation | Circulation
Anticoagulants and Transaminase Elevation | Circulation

Cancers | Free Full-Text | The Hepatic Sinusoid in Chronic Liver Disease:  The Optimal Milieu for Cancer | HTML
Cancers | Free Full-Text | The Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for Cancer | HTML

Nutrients | Free Full-Text | New Perspectives on the Effect of Dandelion,  Its Food Products and Other Preparations on the Cardiovascular System and  Its Diseases | HTML
Nutrients | Free Full-Text | New Perspectives on the Effect of Dandelion, Its Food Products and Other Preparations on the Cardiovascular System and Its Diseases | HTML

Anticoagulation in Concomitant Chronic Kidney Disease and Atrial  Fibrillation: JACC Review Topic of the Week - ScienceDirect
Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week - ScienceDirect

Frontiers | Novel Anti-inflammatory Treatments in Cirrhosis. A  Literature-Based Study
Frontiers | Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study

Cancer-associated venous thromboembolism | Nature Reviews Disease Primers
Cancer-associated venous thromboembolism | Nature Reviews Disease Primers

Frontiers | “Complimenting the Complement”: Mechanistic Insights and  Opportunities for Therapeutics in Hepatocellular Carcinoma
Frontiers | “Complimenting the Complement”: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma

Hepatic Vasculopathy and Regenerative Responses of the Liver in Fatal Cases  of COVID-19 - Clinical Gastroenterology and Hepatology
Hepatic Vasculopathy and Regenerative Responses of the Liver in Fatal Cases of COVID-19 - Clinical Gastroenterology and Hepatology

Resistance to thrombomodulin correlates with liver stiffness in chronic  liver disease a prospective single-center cohort study - Thrombosis Research
Resistance to thrombomodulin correlates with liver stiffness in chronic liver disease a prospective single-center cohort study - Thrombosis Research

Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral  Anticoagulation Have a Net Clinical Benefit for Stroke Prevention? |  Journal of the American Heart Association
Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention? | Journal of the American Heart Association

Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in  Liver Cirrhosis: Implications for Drug Dosage Adjustment | Molecular  Pharmaceutics
Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage Adjustment | Molecular Pharmaceutics

Ultraporous Polyquaternium-Carboxylated Chitosan Composite Hydrogel Spheres  with Anticoagulant, Antibacterial, and Rapid Endotoxin Removal Profiles for  Sepsis Treatment | Biomacromolecules
Ultraporous Polyquaternium-Carboxylated Chitosan Composite Hydrogel Spheres with Anticoagulant, Antibacterial, and Rapid Endotoxin Removal Profiles for Sepsis Treatment | Biomacromolecules

PDF) Anticoagulant therapy in patients with liver cirrhosis and portal vein  thrombosis: insights for the clinician
PDF) Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician

PDF) Anticoagulation in the cirrhotic patient
PDF) Anticoagulation in the cirrhotic patient

Frontiers | Drug-Induced Liver Injury: Biomarkers, Requirements,  Candidates, and Validation
Frontiers | Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation

Design of Carrageenan-Based Heparin-Mimetic Gel Beads as Self-Anticoagulant  Hemoperfusion Adsorbents | Biomacromolecules
Design of Carrageenan-Based Heparin-Mimetic Gel Beads as Self-Anticoagulant Hemoperfusion Adsorbents | Biomacromolecules

Anticoagulation in the cirrhotic patient - ScienceDirect
Anticoagulation in the cirrhotic patient - ScienceDirect

PDF) Oral Anticoagulation in Patients With Liver Disease
PDF) Oral Anticoagulation in Patients With Liver Disease

Anticoagulation in chronic liver disease - Journal of Hepatology
Anticoagulation in chronic liver disease - Journal of Hepatology

Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended  Doses of Direct Oral Anticoagulants | Journal of the American College of  Cardiology
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants | Journal of the American College of Cardiology

Page 192 - Ghidul Serviciilor Medicale Synevo, Ediția 2, Volum 2
Page 192 - Ghidul Serviciilor Medicale Synevo, Ediția 2, Volum 2

Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma -  ScienceDirect
Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma - ScienceDirect